- E-postChristian.Beisland@uib.no
- Telefon+47 55 97 29 02
- BesøksadresseHaukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst5009 Bergen
- PostadressePostboks 78045020 Bergen
Vitenskapelig artikkel
- (2024). Temperature Measurements During Flexible Ureteroscopic Laser Lithotripsy: A Prospective Clinical Trial. Journal of endourology.
- (2024). Prediction of clinically significant recurrence after partial nephrectomy. Data from the Cancer Registry of Norway with more than five years of follow-up. Scandinavian Journal of Urology. 1-9.
- (2024). Outcomes with the Adjustable Transobturator Male System (ATOMS) for the Treatment of Male Stress Urinary Incontinence After Prostate Surgery and the Impact of Previous Radiotherapy. European Urology Open Science. 68-73.
- (2024). Adverse events related to accessory devices used during ureteroscopy: Findings from a 10-year analysis of the Manufacturer and User Facility Device Experience (MAUDE) database. BJUI Compass. 70-75.
- (2024). A preoperative magnetic resonance imaging can aid in staging and treatment choice for upper tract urothelial carcinoma. BJUI Compass.
- (2023). Ureteroscopy in Patients with Urinary Diversion: Outcomes and Lessons Learned from Two European Centres. European Urology Open Science. 85-90.
- (2023). Ureteroscopy for Stone Disease in Extremely Elderly Patients (≥85 Years): Outcomes and Lessons Learned. Journal of endourology. 245-250.
- (2023). Ureteroscopy during pregnancy: Outcomes and lessons learned over 4 decades at a tertiary center in Norway. Current urology. 7-12.
- (2023). Ureteroscopy during pregnancy under local anesthesia and light sedation: Technique and video. Current urology. 219-220.
- (2023). Transitioning from transrectal to transperineal prostate biopsy using a freehand cognitive approach. BJU International.
- (2023). Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 Years. European Urology Oncology (EUO). 8 sider.
- (2023). Patient Perspectives on Kidney Stone Surgery: A Content Analysis of Instagram Posts by Patients Versus Surgeons. European Urology Open Science. 82-86.
- (2023). Paediatric Ureteroscopy (P-URS) reporting checklist: a new tool to aid studies report the essential items on paediatric ureteroscopy for stone disease. Urolithiasis. 6 sider.
- (2023). Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer. Scientific Reports.
- (2023). Local Treatment of Recurrent Renal Cell Carcinoma May Have a Significant Survival Effect Across All Risk-of-recurrence Groups. European Urology Open Science. 65-72.
- (2023). Impact of prebiopsy MRI on prostate cancer staging: Results from the Norwegian Prostate Cancer Registry. BJUI Compass. 331-338.
- (2023). Identifying possible biomarkers of lower urinary tract symptoms using metabolomics and partial least square regression. Metabolomics.
- (2023). Editorial Comment: Thulium fibre laser versus Holmium:YAG for ureteroscopic lithotripsy: outcomes from a prospective randomised clinical trial. International Brazilian Journal of Urology. 267-268.
- (2023). Device Failure and Adverse Events Related to Single-use and Reusable Flexible Ureteroscopes: Findings and New Insights From an 11-Year Analysis of the Manufacturer and User Facility Device Experience Database. Urology.
- (2023). Complications and device failures associated with urolift: Findings from the MAUDE database. Urologia.
- (2023). A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer. Cancer Immunology and Immunotherapy.
- (2022). Ureteroscopy for stone disease in the paediatric population: lessons learned and outcomes in a Nordic setting. Therapeutic Advances in Urology. 1-9.
- (2022). Thulium Fibre Laser versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial. European Urology. 1-7.
- (2022). Temperature profiles during ureteroscopy with thulium fiber laser and holmium:YAG laser: Findings from a pre-clinical study. Scandinavian Journal of Urology. 313-319.
- (2022). Recurrence pattern in localized RCC: results from a European multicenter database (RECUR). Urologic Oncology. 494.e11-494.e17.
- (2022). IPSS “bother question” score predicts health-related quality of life better than total IPSS score. World Journal of Urology. 765-772.
- (2022). A multiomics disease progression signature of low-risk ccRCC. Scientific Reports. 1-15.
- (2021). The levels of IL-6 and soluble IL-33R are increased in the renal vein during surgery for clear cell renal cell carcinoma. Cytokine. 1-10.
- (2021). The epithelial–mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patients. The journal of pathology. Clinical research. 253-270.
- (2021). The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium. European Urology Oncology (EUO). 473-482.
- (2021). Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy? BJU International. 386-394.
- (2021). Rules and regulations for a pregnant endourologist: the European perspective. World Journal of Urology. 8 sider.
- (2021). Prevalence, disease-free, and overall survival of contemporary patients with renal cell carcinoma eligible for adjuvant checkpoint inhibitor trials. Clinical Genitourinary Cancer. 1-8.
- (2021). Preoperative predictors of pathological tumour stage and prognosis may be used when selecting candidates for intensified treatment in upper tract urothelial carcinoma. Scandinavian Journal of Urology. 100-107.
- (2021). Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma. World Journal of Urology. 3823-3831.
- (2021). Higher than expected and significantly increasing incidence of upper tract urothelial carcinoma. A population based study. World Journal of Urology. 1-7.
- (2021). AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease. Cancer Cell International. 12 sider.
- (2020). The biological context of c-reactive protein as a prognostic marker in renal cell carcinoma: Studies on the acute phase cytokine profile. Cancers. 1-18.
- (2020). Serum levels of the IL-6 family of cytokines predict prognosis in renal cell carcinoma (RCC). Cancer Immunology and Immunotherapy. 1-12.
- (2020). Personality and educational level determine self-reported health-related quality-of-life and distress in patients with renal tumors awaiting radical surgery. Scandinavian Journal of Urology. 304-312.
- (2020). Non-metastatic prostate cancer: rationale for conservative treatment and impact on disease-related morbidity and mortality in the elderly. Scandinavian Journal of Urology. 105-109.
- (2020). Magnetic resonance radiomics for prediction of extraprostatic extension in non-favorable intermediate- and high-risk prostate cancer patients. Acta Radiologica. 1570-1579.
- (2020). Assessing extraprostatic extension by mpMRI of the prostate: Mehralivand’s EPE grade or EPE Likert score? Radiology: Imaging Cancer. 1-10.
- (2019). Tumour architecture, grade and location remain predictors of non-organ-confined upper tract urothelial carcinoma at time of radical nephroureterectomy: results from a multicenter Norwegian external validation study. World Journal of Urology. 717-723.
- (2019). Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms. American Journal of Physiology - Renal Physiology (AJP).
- (2019). Increased use of cross-sectional imaging for follow-up does not improve post-recurrence survival of surgically treated initially localized R.C.C.: results from a European multicenter database (R.E.C.U.R.). Scandinavian Journal of Urology. 14-20.
- (2019). FOXC2 expression and epithelial–mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer. The journal of pathology. Clinical research. 272-286.
- (2019). Elevated plasma interleukin 6 predicts poor response in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. Cancer Treatment and Research Communications. 1-5.
- (2018). Use of venous-thrombotic-embolic prophylaxis in patients undergoing surgery for renal tumors: a questionnaire survey in the Nordic countries (The NORENCA-2 study). Open Access Journal of Urology. 181-187.
- (2018). Tumour cell expression of interleukin 6 receptor a is associated with response rates in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. The journal of pathology. Clinical research. 114-123.
- (2018). Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma. New England Journal of Medicine. 417-427.
- (2018). Novel protein signatures suggest progression to muscular invasiveness in bladder cancer. PLOS ONE. 1-15.
- (2018). National Norwegian Practice Patterns for Surgical Treatment of Kidney Cancer Tumors ≤7cm: Adherence to Changes in Guidelines May Improve Overall Survival. European Urology Oncology (EUO). 252-261.
- (2018). Long-term outcomes of follow-up for initially localised clear cell renal cell carcinoma: RECUR database analysis. European Urology Focus. 857-866.
- (2018). Intensive imaging-based follow-up of surgically treated localised renal cell carcinoma does not improve post-recurrence survival: Results from a European multicentre database (RECUR). European Urology. 1-4.
- (2018). Intensity-based volumetric registration of magnetic resonance images and whole-mount sections of the prostate. Computerized Medical Imaging and Graphics. 24-30.
- (2018). Fine needle aspirates of kidneys: A promising tool for RNA sequencing in native and transplanted kidneys. BMC Nephrology. 1-9.
- (2018). External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. World Journal of Urology. 1-8.
- (2018). Expanding the utilization of formalin-fixed, paraffin-embedded archives: Feasibility of miR-Seq for disease exploration and biomarker development from biopsies with clear cell renal cell Carcinoma. International Journal of Molecular Sciences. 1-18.
- (2018). Dictionary-based through-plane interpolation of prostate cancer T2-weighted MR images. Signal Processing - Algorithms, Architectures, Arrangements, and Applications Conference Proceedings, SPA. 168-173.
- (2018). CRF-Based clustering of pharmacokinetic curves from dynamic contrast-enhanced MR images. Signal Processing - Algorithms, Architectures, Arrangements, and Applications Conference Proceedings, SPA. 174-179.
- (2017). Use of diagnostic biopsies in kidney tumors. Scandinavian Journal of Urology. 185-192.
- (2017). Rule-based data-driven approach for computer aided diagnosis of the peripheral zone prostate cancer from multiparametric MRI: Proof of concept. Signal Processing - Algorithms, Architectures, Arrangements, and Applications Conference Proceedings, SPA. 90-95.
- (2017). Reconstruction of high-resolution T2W MR images of the prostate using maximum a posteriori approach and Markov random field regularization. Signal Processing - Algorithms, Architectures, Arrangements, and Applications Conference Proceedings, SPA. 96-99.
- (2017). Real-life use of diagnostic biopsies before treatment of kidney cancer: results from a Norwegian population-based study. Scandinavian Journal of Urology. 38-44.
- (2017). Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. BMC Urology. 1-11.
- (2017). Overall Survival in Renal Cell Carcinoma after Introduction of Targeted Therapies: A Norwegian Population-Based Study. OncoTargets and Therapy. 371-385.
- (2017). Optimising preoperative risk stratification tools for prostate cancer using mpMRI. European Radiology. 1016-1026.
- (2017). Incidental detection of renal cell carcinoma. Scandinavian Journal of Urology. 178-184.
- (2017). Contemporary treatment of renal tumors: a questionnaire survey in the Nordic countries (the NORENCA-I study). Scandinavian Journal of Urology. 360-366.
- (2017). Clear cell renal cell carcinoma is linked to epithelial-to-mesenchymal transition and to fibrosis. Physiological Reports. 1-18.
- (2016). Trends in stage-specific incidence of prostate cancer in Norway, 1980–2010: a population-based study. BJU International. 547-555.
- (2016). Transcriptome sequencing (RNAseq) enables utilization of formalin-fixed, paraffin-embedded biopsies with clear cell renal cell carcinoma for exploration of disease biology and biomarker development. PLOS ONE.
- (2016). RNA extraction for RNA sequencing of archival renal tissues. Scandinavian Journal of Clinical and Laboratory Investigation. 426-434.
- (2016). Postoperative 30-day mortality rates for kidney cancer are dependent on hospital surgical volume: results from a Norwegian population-based study. European Urology Focus. 300-307.
- (2016). Nephron Sparing Surgery Associated with Better Survival Than Radical Nephrectomy in Patients Treated for Unforeseen Benign Renal Tumors. Urology. 117-123.
- (2016). Grading of urothelial carcinoma of the upper urinary tract according to the World Health Organization/International Society of Urological Pathology classification from 2004 is a valuable tool when considering whether a patient is suitable for endoscopic treatment. Scandinavian Journal of Urology. 298-304.
- (2016). Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell carcinoma patients. Acta Oncologica. 349-356.
- (2016). Development and confirmation of potential gene classifiers of human clear cell renal cell carcinoma using next-generation RNA sequencing. Scandinavian Journal of Urology. 452-462.
- (2016). A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use. World Journal of Urology. 1087-1099.
- (2016). A positive Real-Time Elastography (RTE) combined with a Prostate Cancer Gene 3 (PCA3) score above 35 convey a high probability of intermediate- or high-risk prostate cancer in patient admitted for primary biopsy. BMC Urology. 1-8.
- (2015). Prostate cancer antigen-3 (PCA3) and PCA3-based nomograms in the diagnosis of prostate cancer: an external validation of Hansen's nomogram on a Norwegian cohort. Scandinavian Journal of Urology. 8-15.
- (2015). Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma. Scandinavian Journal of Urology. 388-394.
- (2015). Health-related quality of life, personality and choice of coping are related in renal cell carcinoma patients. Scandinavian Journal of Urology. 282-289.
- (2015). Contemporary external validation of the Leibovich model for prediction of progression after radical surgery for clear cell renal cell carcinoma. Scandinavian Journal of Urology. 205-210.
- (2015). 1.5-T multiparametric MRI using PI-RADS: a region by region analysis to localize the index-tumor of prostate cancer in patients undergoing prostatectomy. Acta Radiologica. 500-511.
- (2014). Langtidsoverlevelse etter behandling av overgangsepitelkarsinom i ureter og nyrebekken. Kirurgen. 113-116.
- (2014). Health-related quality of life in long-term survivors after renal cancer treatment. Scandinavian Journal of Urology and Nephrology. 52-64.
- (2014). A positive real-time elastography is an independent marker for detection of high-risk prostate cancers in the primary biopsy setting. BJU International. E90-E97.
- (2013). Incidentally detected renal cell carcinomas are highly associated with comorbidity and mortality unrelated to renal cell carcinoma. Scandinavian Journal of Urology and Nephrology. 462-471.
- (2013). Does a surgeon’s annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? Findings from a prospective national study. Scandinavian Journal of Urology and Nephrology. 92-100.
- (2012). Ureterskadar og handsaming av desse. Kirurgen. 217-219.
- (2012). Testikkeltorsjoner behandlet ved Haukeland universitetssjukehus i årene 2000-2008. Kirurgen. 212-215.
- (2012). Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma. Scandinavian Journal of Urology and Nephrology. 348-357.
- (2012). Combination of real-time elastography and urine prostate cancer gene 3 (PCA3) detects more than 97 % of significant prostate cancers. Scandinavian Journal of Urology and Nephrology. 211-216.
- (2009). Observation should be considered as an alternative in management of renal masses in lder and comorbid patients. European Urology. 1419-1429.
- (2006). Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study. BJU International. 698-702.
- (2004). Vitiligo--an autoimmune side-effect of intravesical bacillus Calmette-Guerin instillation? Scandinavian Journal of Urology and Nephrology. 182-183.
- (2004). Presumed radically treated renal cell carcinoma--recurrence of the disease and prognostic factors for subsequent survival. Scandinavian Journal of Urology and Nephrology. 299-305.
- (2004). Natural and clinical course of renal cell carcinoma--better prospect for the patients. Scandinavian Journal of Surgery. 97-101.
- (2002). Nyrekreft - en retrospektiv undersøkelse av 368 pasienter. Tidsskrift for Den norske legeforening. 2431-2435.
Faglig foredrag
- (2015). Post ASCO GU 2015 - Nyre/ Blære; Hva er nytt!
Vitenskapelig foredrag
- (2023). Survival and biomarkers in a prospective non-randomized phase I trial of dendritic cell-based cryoimmunotherapy combined with checkpoint inhibitors in metastatic castration-resistant prostate cancer (mCRPC) .
- (2019). Personality and choice of coping are important for self-reported health-related quality of life in patients with renal tumors prior to radical surgery.
- (2019). Level of distress is closely related to personality and choice of coping in patients with renal tumors prior to radical surgery.
- (2019). Cytoreductive and palliative renal surgery.
- (2013). Psykometrisk validering av et diagnosespesifikt livskvalitets- skjema (HRQoL,) ment brukt sammen med det generelle EORTC livskvalitests- skjemaet (QLQ) på nyrekreft-pasienter.
- (2013). Psychometric validation of a disease-specific Health Related Quality of Life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization of Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in Renal Cell Carcinoma patients.
- (2012). Radiologisk vs. patologisk størrelse av nyrecellecarcinomer i stadium I og II - betydning for stadiumspesifikk overlevelse.
- (2012). Radikale prostatektomier ved Haukeland universitetssjukehus 2010-2012.
- (2012). Pyeloplastikk på barn - erfaringer fra Haukeland universitetssjukehus 2001-2011.
- (2012). Oppstart med behandling av postprostatektomi inkontinens (PPI) ved Haukeland universitetssjukehus.
- (2012). Læringskurven for RALP ved Haukeland universitetssjukehus 2010-2012.
- (2012). Lymfekjerteltoilette (PLND) ved radikale prostatektomier ved Haukeland universitetssjukehus 2010-2012.
- (2012). Evaluering av oppfølgningsprogrammet for nyrekreft (RCC)ved Haukeland universitetssjukehus.
- (2010). Real time elastografi ved cancer prostatae.
- (2010). Preliminære resultater av PCA3 måling i urin hos pasienter med cancer prostatae.
- (2010). Er preoperativ MR-prostata nyttig for å avklare korrekt T-stadium forut for kirurgi?
- (2010). Er MR-prostata nyttig for å avklare videre oppfølgningsbehov hos pasienter med 2 eller flere negative biopsiserier?
- (2002). Overlevelse etter metastasering fra nyrecelle carcinom (RCC) - hvilke prognostiske faktorer har betydning?
- (2002). Innføring av laparoskopisk PLND ved cancer prostatae som standard operasjonsmetode - gir det noen gevinst?
- (2002). Genital selvmutilering (GSM) - ren skjær galskap eller .. ?
- (1991). Ileal Conduit ad modum Bricker. Complications and Quality of Life. .
Leder
- (2020). Cytoreductive nephrectomy in primary metastatic clear cell renal cell carcinoma. Scandinavian Journal of Urology.
Leserinnlegg
- (2023). PSA-testen må brukes smartere. Tidsskrift for Den norske legeforening.
- (2013). Untitled. American Journal of Clinical Oncology. 423-423.
Short communication
- (2023). A prospective non-randomized phase I trial of dendritic cell–based cryoimmunotherapy combined with checkpoint inhibitors in mCRPC. Journal of Clinical Oncology.
Brev til redaktøren
- (2023). Traffic light system for simplified decision-making for stent insertion and removal at the time of ureteroscopy. Urolithiasis.
- (2023). The Butterfly: A Novel Minimally Invasive Transurethral Retraction Device for Benign Hypertrophy of the Prostate. Urologia internationalis.
- (2023). Adult Ureteroscopy (A-URS) Checklist: A New Tool To Standardise Reporting in Endourology. European Urology Open Science. 1-5.
- (2022). Ureteroscopy in pregnancy can be a preferred option and not just a last resort. World Journal of Urology.
- (2022). Reply to Jinze Li, Yin Huang, Dehong Cao, and Qiang Wei's Letter to the Editor re: Øyvind Ulvik, Mathias Sørstrand Æsøy, Patrick Juliebø-Jones, Peder Gjengstø, Christian Beisland. Thulium Fibre Laser Versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial. Eur Urol. 2022;82:73–79. European Urology. e72.
- (2022). Reply to Hyung Joon Kim and Khurshid R. Ghani's Letter to the Editor re: Øyvind Ulvik, Mathias Sørstrand Æsøy, Patrick Juliebø-Jones, Peder Gjengstø, Christian Beisland. Thulium Fibre Laser Versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial. Eur Urol. 2022;82:73–9. European Urology. e41-e42.
- (2022). Reply to Frederic Panthier, Alba Sierra, and Olivier Traxer's Letter to the Editor re: Øyvind Ulvik, Mathias Sørstrand Æsøy, Patrick Juliebø-Jones, Peder Gjengstø, Christian Beisland. Thulium Fibre Laser Versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial. Eur Urol. 2022;82:73–9. European Urology. e37-e38.
- (2022). Reply to Alan J. Yaghoubian, Jonathan A. Khusid, and Mantu Gupta's Letter to the Editor re: Øyvind Ulvik, Mathias Sørstrand Æsøy, Patrick Juliebø-Jones, Peder Gjengstø, Christian Beisland. Thulium Fibre Laser Versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial. Eur Urol. 2022;82:73–9. European Urology. e45-e46.
- (2013). Letter to the Editor. American Journal of Clinical Oncology. 423-423.
Doktorgradsavhandling
- (2019). Late-Stage Prostate Cancer and Prostate Cancer Mortality. A Population-Based Study.
- (2018). A population based study on Kidney Cancer in Norway (2008 - 2013).
- (2006). Epidemiological and Clinical Aspects in Diagnosis and Treatment of Renal Cell Carcinoma.
Sammendrag/abstract
- (2022). Development of an EORTC Quality of Life Module for Renal Cell Cancer Patients: Phase I. European psychiatry. S756-S756.
- (2016). Perioperative 30-day mortality rates are dependent on hospital surgical volume – results from a Norwegian population based study on surgical treatment for renal cell carcinoma. European Urology. Supplement. e520.
- (2016). Changes in surgical treatment of modalities for renal cell carcinoma ≤ 7 cm – a Norwegian population based study 2008-2013. European Urology. Supplement. e1089.
- (2013). Survival after treatment for urothelial carcinoma in the upper urinary tract. Results of the final analysis-25 years postsurgery. Scandinavian Journal of Urology and Nephrology. 33-33.
- (2013). Serum VEGF in patients with renal tumours and low contrast enhancement on ct can be used to predict survival and recurrence. Scandinavian Journal of Urology and Nephrology. 32-33.
- (2013). Health related quality of life (HRQoL), personality and choice of coping is associated in renal cell carcinoma patients. Scandinavian Journal of Urology and Nephrology. 33-34.
Poster
- (2023). Survival and biomarkers in a prospective non-randomized phase I trial of dendritic cell-based cryoimmunotherapy combined with checkpoint inhibitors in metastatic castration-resistant prostate cancer (mCRPC).
- (2022). Quality assessment of transurethral resection of bladder tumours (TURB) and association between bladder lesion appearances and malignancy: Findings from a Norwegian tertiary centre.
- (2022). Cancer patients ≥80 years of age admitted for surgical treatment – Baseline characteristics from the elderly somatic cancer patient study (ELDSOCA).
- (2021). Development of an EORTC Quality of Life Module for Renal Cell Cancer Patients: Phase I.
- (2019). Helse og livskvalitet hos kognitivt intakte elektive kreftpasienter over 80 år .
- (2018). Fine needle aspirates of kidneys are usable for RNA sequencing like regular core biopsies.
- (2018). Expanding the utilization of formalin-fixed, paraffin-embedded archives: Feasability of miRNA-sequencing for disease exploration and biomarker development from biopsies with clear cell renal cell carcinoma.
- (2016). Detection and Validation of Epithelial-to-Mesenchymal Transition(EMT) with Increased Expression of Axl and MMP-14 in Renal Cell Carcinoma.
- (2015). C-reactive protein as a predictive marker of response to sunitinib treatment in metastatic clear cell renal cell carcinoma.
- (2014). Registration of multiparametric MRI and whole-mount sections of the prostate.
- (2014). Registration of multiparametric MRI and whole-Mount sections prostate.
- (2013). Health related quality of life (HRQoL) personality and choice of coping is associated in renal cell carcinoma patinets.
Errata
- (2023). Correction to: Current status of patient-reported outcome measures and other subjective assessment grading tools in bladder pain syndrome (International Urogynecology Journal, (2023), 10.1007/s00192-023-05551-z). International Urogynecology Journal.
- (2021). Corrigendum to “The levels of IL-6 and soluble IL-33R are increased in the renal vein during surgery for clear cell renal cell carcinoma” [Cytokine 144 (2021) 155586](S1043466621001691)(10.1016/j.cyto.2021.155586). Cytokine.
Vitenskapelig oversiktsartikkel/review
- (2024). Measuring quality of life in patients with kidney stone disease: Is it the future in endourology? Current Opinion in Urology. 91-97.
- (2023). Single use flexible ureteroscopes: Current status and future directions. BJUI Compass. 613-621.
- (2023). Refractory Bladder Neck Contracture (BNC) After Radical Prostatectomy: Prevalence, Impact and Management Challenges. Open Access Journal of Urology. 495-507.
- (2023). Paediatric kidney stone surgery: state-of-the-art review. Therapeutic Advances in Urology.
- (2023). Outcomes Associated with the Endourological Management of Stent Encrustation: Findings from a Literature Review on Behalf of the EAU YAU Urolithiasis Group. Current Urology Reports. 187-199.
- (2023). Holmium and Thulium Fiber Laser Safety in Endourological Practice: What Does the Clinician Need to Know? Current Urology Reports. 409-415.
- (2023). Current status of patient-reported outcome measures and other subjective assessment grading tools in bladder pain syndrome. International Urogynecology Journal.
- (2022). Management of kidney stone disease in pregnancy: A practical and evidence-based approach. Current Urology Reports. 8 sider.
- (2022). Management of Bladder Pain Syndrome (BPS): A Practical Guide. Advances in Urology. 1-9.
- (2022). Current status of nomograms and scoring systems in paediatric endourology: A systematic review of literature. Journal of Pediatric Urology. 13 sider.
- (2022). Advances in Ureteroscopy: New technologies and current innovations in the era of Tailored Endourological Stone Treatment (TEST). Journal of Clinical Urology (JCU). 1-9.
- (2021). Endourological management of encrusted ureteral stents: an up-to-date guide and treatment algorithm on behalf of the European Association of Urology Young Academic Urology Urolithiasis Group. Central European Journal of Urology. 571-578.
- (2021). Current status of thulium fibre laser lithotripsy: an up-to-date review. BJU International. 531-538.
- (2021). Current Status of Intravesical Therapies for Bladder Pain Syndrome (BPS): A Narrative Review of Emerging Evidence. Urology. e48-e57.
- (2014). Traumatiske skader i nyra – ei orientering for dei utan spesialistkompetanse. Kirurgen. 119-123.
- (2008). Radikal behandling av Cancer Renis – En oversikt for kirurger. Kirurgen. 12-15.